Main > RHEUMATOLOGY > Rheumatoid Arthritis > Treatment > Co.: USA. B. BioSimilar AdalimuMAb

---

Co.: USA. B. BioSimilar AdalimuMAb's subsections
(*) EU Approval Date: 2017. 08.24
Company
Developed By:
TradeMark

Co.: USA. B. BioSimilar AdalimuMAb's products
This section has no products